Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 68M | 58M |
| Research and development | 389M | 466M |
| Selling, general and administrative | 120M | 126M |
| Operating expenses | 509M | 592M |
| Operating income | −441M | −534M |
| Net income | −413M | −519M |
| Earnings per share | −3.81 | −5.25 |
| Earnings per share, diluted | −3.81 | −5.25 |
| Weighted average shares | 108M | 99M |
| Weighted average shares, diluted | 108M | 99M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 135M | 155M | 193M | 156M | 127M | 189M | 120M | 131M |
| Short-term investments | 241M | 294M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −395M | −349M |
| Depreciation and amortisation | 10M | 10M |
| Share-based compensation | 80M | 154M |
| Capital expenditure | 1M | 6M |
| Investing cash flow | 228M | 126M |
| Financing cash flow | 131M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 318M |
| 303M |
| 377M |
| 412M |
| 538M |
| 560M |
| Receivables | 9M | 9M | 11M | 11M | 11M | 9M | 9M | 12M |
| Current assets | 466M | 528M | 582M | 496M | 551M | 640M | 711M | 757M |
| Property, plant and equipment | 16M | 18M | 20M | 23M | 25M | 27M | 29M | 30M |
| Total assets | 759M | 842M | 925M | 899M | 986M | 1.19B | 1.17B | 1.19B |
| Current liabilities | 76M | 104M | 94M | 95M | 113M | 111M | 106M | 105M |
| Total liabilities | 138M | 171M | 177M | 184M | 206M | 319M | 211M | 220M |
| Equity | 621M | 671M | 748M | 715M | 780M | 872M | 963M | 971M |
| Shares outstanding | 120M | 116M | 116M | 105M | 104M | 102M | 102M | 98M |
| Shares issued | 120M | 116M | 116M | 105M | 104M | 102M | 102M | 98M |
| 186M |